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Abstract
Improvements in the fields of membrane-protein molecular biology and biochemistry, technical
advances in structural data collection and processing, and the availability of numerous sequenced
genomes have paved the way for membrane-protein structural genomics efforts. There has been
significant recent progress, but various issues essential for high-throughput membrane-protein
structure determination remain to be resolved.
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The goal of determining the structure of membrane proteins
continues to define a substantial region of the structural
biology horizon. While significant progress has been made
over the past five years, the ratio of structures solved for
membrane proteins to those solved for soluble proteins
remains small, such that membrane proteins comprise less
than 1 in 100 of the structures deposited in the Protein Data
Bank (PDB) [1]. 
Although the total number of membrane-protein structures
determined to date is but a small fraction of all protein struc-
tures determined, the more than 100 structures on deposit in
public databases represent a substantial start. A burgeoning
database [2] already contains examples of proteins with
seven transmembrane helices, ion and water channels, trans-
porters, ATPases, porins, toxins, and an array of proteins
involved in energy production. While substantial architec-
tural diversity can be found among the membrane-protein
structures determined to date, they clearly fall into one of
two general categories, those containing -helical trans-
membrane regions and those with transmembrane regions
composed of  strands arranged to form barrel-like struc-
tures, the latter being primarily represented by the porins of
bacterial outer membranes. Examples of structures from
these two categories are shown in Figure 1.
The relatively small number of membrane-protein structures
determined to date stems primarily from the requirement
for solubilization of membrane proteins before crystalliza-
tion, while preserving the structural integrity of the solubi-
lized protein. Despite this challenge, the need to increase the
number of known membrane-protein structures is clear and
is further emphasized by the estimate that more than 30% of
a typical cell’s proteins are membrane proteins [3] and that
more than half of all membrane proteins are predicted to be
pharmaceutical targets [4]. The recent modest increase in
the rate of determining membrane-protein structures has
been facilitated by improvements in the areas of membrane-
protein molecular biology and biochemistry, and through
technical advances in synchrotron X-ray beamlines for crys-
tallography, high-field nuclear magnetic resonance (NMR)
and high-resolution electron microscopy. The availability of
sequenced genomes spanning a broad range of species has
vastly improved searches for structural homologs and the
prediction of previously unknown membrane proteins.
These factors have converged to help set the stage for the
determination of membrane-protein structures rapidly and
on a large scale. 
In recent years a number of consortia, bringing together
researchers from a variety of academic and research institutions
[5-7], have been established to address and execute the goals
of structural genomics - that is, to dramatically increase the
database of known protein structures by developing and
applying methodologies to determine them as rapidly and
cost-effectively as possible. To date, however, only one group(Mycobacterium tuberculosis Membrane Protein Structural
Genomics [8]) has taken on as its primary mission the high-
throughput determination of membrane-protein structures.
While the efforts of this group are ongoing, substantial
progress has already been made in the construction of
expression vectors on a large scale.
This article provides an overview of the factors essential for
the determination of membrane-protein structures in high-
throughput fashion and the progress that has been made so
far in these areas. The key issues that arise for a researcher
who wishes to determine the structure of membrane pro-
teins at the atomic level are: how to produce sufficient
protein, and once produced how to solubilize and purify the
protein; then, how to crystallize the protein, or whether
instead to study it in solution; and finally, how to scale up
such methods for high-throughput structure determination.
Protein overexpression
Target selection
High-resolution structure-determination efforts typically
require milligram quantities of proteins. Overexpression of
prokaryotic genes in bacterial vectors currently provides the
most direct and productive route to fulfilling this need
[9,10]. Studies on genes with introns will require full-length
cDNAs derived from mRNA libraries, and this represents
another degree of complexity. Groups such as the Mam-
malian Gene Collection (MGC) [11], for example, have
created resources for the production and distribution of full-
length human genes [12].
Prokaryotic genomes are also logical choices as target
genomes for membrane-protein structural genomics efforts
[13]. The initial goals of these efforts will be to clone, overex-
press and purify the known and putative membrane proteins
of their selected genomes. Potential membrane-protein
targets can be identified from functional studies or on the
basis of knowledge from previously characterized homolo-
gous genes. In many instances, however, homology-based
predictions of protein type and function will not be possible.
For these proteins, assignment of putative membrane-
protein status will have to be based on predictions of trans-
membrane segments using the many bioinformatic tools
now available (for example, see [14]).
Ideally, all successfully expressed and solubilized target mem-
brane proteins should be distributed to X-ray and electron
crystallography groups, and appropriate protein samples to
NMR spectroscopy teams, for simultaneous efforts at struc-
ture determination and maximization of the likelihood that
rapid progress will be made.
Expression constructs
Once a membrane protein has been prioritized, by whatever
means, for structure determination, the next step must be to
overexpress the protein in a way that allows significant
quantities to be isolated and purified for further study. The
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Figure 1
Membrane-protein models representing the two general categories of transmembrane-region structure. (a) Side-view of BtuCD Vitamin B12
Transporter [51] containing an -helical transmembrane region (PDB accession code 1L7V); and (b) side-view of FecA Ferric Citrate Uptake Receptor
[52] featuring a -barrel transmembrane region (PDB accession code 1KMO). Light gray blocks on the sides of each model depict the approximate limits
of the lipid bilayer. The figure was produced using MOLSCRIPT [53] and Raster3D [54].
(a) (b)majority of structural genomics consortia are pursuing high-
throughput protein expression through constructs expressed
in Escherichia coli. Expression in E. coli has numerous
attributes that make it such a strong choice. It has clear
advantages currently with respect to cost per gene
expressed, the variety of specialized expression vectors avail-
able and the well-developed methods for labeling target pro-
teins for NMR and X-ray diffraction studies [9,10]. 
Expression vectors based on promoters used by T7 RNA poly-
merase are in widespread use for the overexpression of
soluble proteins among the various consortia [9,10]. It also
appears that for the immediate future this class of vectors will
be favored by research groups overexpressing membrane
proteins. One concern, especially with respect to the overex-
pression of membrane proteins, is the effect of target-protein
expression levels in the uninduced state (‘leakiness’) on host-
cell health, and subsequently on the ability to overexpress
properly folded proteins at high levels. Vectors with promot-
ers less prone to leakage expression may have to be sought for
the successful overexpression of certain membrane proteins.
Purification of overexpressed protein is greatly simplified and
idealized for high-throughput studies through the use of con-
structs in which the target gene is fused to an affinity tag,
whereby the tag can be placed at either the amino- or the
carboxy-terminal end of the target protein, with a number of
options in construct design. Examples of tags include glu-
tathione S-transferase, maltose-binding protein and polyhisti-
dine. By virtue of their ease of use, polyhistidine tags have
seen the broadest application [9,10]. Although there are indi-
cations that amino-terminal polyhistidine-tag fusion proteins
may have a better expression record with respect to mem-
brane proteins [8], in our view the performance of both
amino- and carboxy-terminal tagged constructs should be
evaluated on a case-by-case basis with respect to target-
protein overexpression, solubility, and crystallizability. To
facilitate the subsequent removal of affinity tags, protease
recognition sites can also be incorporated into the constructs;
and in the case of membrane proteins it is desirable that these
sites support the use of detergent-resistant proteases, so as to
be compatible with detergent-based purification procedures.
Structure-determination efforts on human gene products
have been limited, because of difficulties in obtaining high
expression levels of protein. Many human genes will proba-
bly require some form of eukaryotic expression vector for
successful overexpression. Numerous yeast, insect and
mammalian cell lines could potentially serve in this capacity
[13]; the development of eukaryotic expression methodolo-
gies tailored for high-throughput applications, however, is
still in the nascent stages.
Host cells
The choice of host cells for overexpression of a given protein
will depend on various factors, such as the source of the origi-
nal gene, the protein’s fold complexity and the potential need
for folding partners, and requirements for post-translational
modification. As discussed earlier, the use of E. coli expres-
sion vectors runs strongly across the various structural
genomics consortia and, in turn, dictates that some strain of
E. coli will serve as host cell. Although there are a number of
strains that have been used to express membrane proteins,
BL21 (DE3) and a derivative of BL21 optimized for mem-
brane-protein expression (designated C43) appear to be best
suited for the task. Strain variant C43 grows more slowly than
BL21, and in doing so may provide more time for the host cell
to deal properly with higher than normal levels of membrane-
protein expression [15]. Expression of both soluble and mem-
brane proteins in a given bacterial strain can be quite
sensitive to post-induction incubation temperature. The
amount of overexpressed target membrane protein localized
within lipid bilayers may be increased, and the occurrence of
inclusion bodies containing aggregated protein reduced, by
lowering incubation temperatures following induction.
Although not as practical for high-throughput purposes as
bacterial expression systems, certain eukaryotic target pro-
teins, either single polypeptides or those of multiple subunit
complexes, may require ‘higher’ cell types to achieve ade-
quate expression. Potential drawbacks to the use of eukary-
otic cell types can derive from difficulties in protein isolation
and yield, longer doubling times, and cost. Dealing with
post-translational modifications, such as the removal of gly-
cosylation usually required for success in crystallization, can
be particularly challenging and may require inhibition of the
host cell’s glycosylation pathway during expression, or modi-
fication of the construct sequence, or treatment of expressed
proteins with glycosidases [16]. 
Cell-free systems
Although still an evolving technology, cell-free expression
systems offer an alternative methodology for the overexpres-
sion of proteins [17-19]. In such a system, essential protein
expression machinery is obtained from cell lysates, which
can be isolated and prepared in-house or obtained from
commercial sources. Commercial systems are presently
available with an advertised capability of producing 150 mg
of protein from 30 ml of reaction mixture over a 24-hour
time period [20]. Clearly this level of expression is well suited
for high-throughput structural studies. For membrane pro-
teins, however, expression away from lipid bilayer environ-
ments can, understandably, result in problems with protein
folding and solubility. Supplementation of the reaction mix-
tures with detergents and lipids may provide a means of
extending the utility of this approach to membrane proteins.
Solubilization and purification
Selection of solubilization detergents
Once sufficiently high level expression of the target membrane
protein has been established, preferably in the host-cell
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best-suited for solubilization and subsequent purification.
A wide variety of detergents suitable for membrane-
protein solubilization are currently available (see, for
example, [21]). Some of the most popular detergent fami-
lies include the alkyl glucosides and maltosides, poly-
oxyethylenes, alkyldimethylamine oxides, and cholate
derivates. Experience has shown that the detergent
selected for membrane extraction may not be the deter-
gent of choice for crystallization. Broadly speaking, both
the length of the detergent’s hydrocarbon chain
(hydrophobic domain) and the size of its polar head group
(hydrophilic domain) are major factors affecting the sta-
bility of the solubilized protein - longer chain lengths and
larger head groups are generally more favorable for the
stability of the protein. When necessary, solubilizing
detergents can be exchanged for other detergents through
dialysis, or while the target protein is bound to chromato-
graphic media. Some factors that need to be evaluated in
choosing a detergent at the solubilization stage may be
extraction yield, stability of the solubilized protein, and cost.
A particularly important criterion in selecting a detergent is
its effect on a protein’s structure and function. Certain deter-
gents, particularly ionic ones, can denature membrane pro-
teins, even when used at relatively low concentrations.
Undesirable outcomes can involve varying degrees of denat-
uration, separation of subunits from multimeric or multi-
subunit complexes, and aggregation [13]. Such potential
results should be avoided prior to attempting crystallization
and in collecting solution NMR data, for which samples
should be monodisperse and stable, often at concentrations
up to 10 mg/ml [10,22].   
Evaluation of a detergent’s effect on target-protein stability
can provide a relatively quick means of assessing a deter-
gent’s suitability. One simple but effective test we have used
involves solubilizing target proteins in candidate detergents
and storing the mixtures overnight at room temperature.
The various preparations can then be quickly evaluated to
determine whether or not the protein has precipitated.
Those solubilized proteins appearing stable can be exam-
ined more closely to determine the extent of homogeneity.
Molecular-sieve chromatography, which separates molecules
primarily by size, can reveal protein aggregation and/or
oligomerization, as well as provide a means of improving
sample homogeneity. Dynamic light scattering is another
approach that can provide much of the same information
about particle size as molecular-sieve chromatography, but
more rapidly [23]. A form of NMR spectroscopy, hetero-
nuclear single quantum correlation (HSQC), can also be
used as a screening tool for the rapid assessment of target-
protein quality [22]. If the function of a target protein is
known or confidently predicted, functional assays should
ideally be used to ensure that the protein is fully active in
the candidate detergent. 
Purification 
As in the case of high-throughput structure-determination
efforts for soluble proteins, the process of purifying overex-
pressed membrane proteins has been substantially stream-
lined through the use of affinity tags. When coupled to the
output of optimized host-cell systems, milligram quantities
of relatively pure protein can be obtained following a single
chromatographic step [13]. In many instances the target
protein will already be sufficiently pure at this stage to begin
structure-determination efforts. During this phase of purifi-
cation it is also appropriate to address the possibility of
whether the solubilizing detergent used is suitable for crys-
tallization and for maintaining a monodisperse solution
when the protein is highly concentrated. The effects of alter-
native detergents can be investigated by exchanging deter-
gents while the target protein is bound to the affinity
column. Should the affinity-column-purified sample require
further cleanup, use of molecular-sieve chromatography is
usually sufficient to remove minor contaminants and aggre-
gates. On those occasions when residual contaminants
cannot be isolated from the target protein on the basis of
molecular weight differences, an alternative additional chro-
matographic step, such as ion-exchange chromatography,
may be necessary [10].
Structure determination
There are currently several approaches for determining the
structure of membrane proteins, notably X-ray crystallogra-
phy, electron crystallography and NMR spectroscopy. Given
its history of demonstrated success, X-ray crystallography is
regarded as the most widely proven tool for structure-
determination efforts. But target-protein characteristics,
such as molecular weight, solubility and crystallizability,
may dictate that other methodologies are better suited for a
particular gene product. For example, small detergent-solu-
bilized membrane proteins or peptides with a very large
hydrophobic surface area to volume ratio, which may not
have good solubility properties at high concentration, may
be excellent candidates for NMR spectroscopy.
X-ray crystallography
X-ray crystallography provides an established means for
obtaining high-resolution structural data from membrane
proteins. With this approach, molecular weight seldom limits
the choice of target protein, and determination of structures
at atomic-level resolution is a very realistic goal. Often dif-
fraction from a single crystal is sufficient for high-resolution
structure determination. In many cases, the difficulties that
were in the past associated with interpreting X-ray diffraction
amplitudes in terms of how they reflect the underlying crystal
structure - known as the ‘phase problem’ - have been dramat-
ically reduced through the use of multi-wavelength anom-
alous diffraction techniques that rely on the use of X rays of
multiple wavelengths and externally provided anomalously
scattering atoms that yield reference points within the crystal
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sources facilitate the rapid phasing of diffraction data
obtained from selenomethionine-derivatized target proteins,
prepared through the metabolic labeling of proteins
expressed in E. coli. Synchrotron X-ray sources also make it
possible to obtain high-resolution datasets from microcrys-
tals [25], which are often no larger than 50 m in their
longest dimension, reducing potential bottlenecks associated
with the need to optimize crystallization conditions in an
effort to obtain large crystals. Further gains in sample
throughput rates can be realized through automation-
assisted screening of sample wells for the presence of crystals,
and automated crystal handling and data collection.
The major challenge of the X-ray diffraction structure-deter-
mination approach lies in obtaining suitable three-dimen-
sional crystals. As with soluble proteins, homogeneity and
stability of the purified protein at high concentration is often
critical for obtaining crystals. The strategies for crystallizing
membrane proteins are similarly centered on reducing the
solubility of the target protein under conditions that allow
for the establishment of crystal-forming contacts between
neighboring molecules [26]. Protein solubility is typically
lowered through the use of precipitating agents, such as
ammonium sulfate and polyethylene glycols. Experimentally
variable parameters affecting the degree and nature of mole-
cule-to-molecule contact include pH, ionic strength and
temperature. A factor unique to the crystallization of mem-
brane proteins is the presence of the substantial concentra-
tions of detergent required to maintain solubility of the
target protein. To ensure solubility of a target protein the
concentration of detergent must be kept above the critical
micelle concentration (CMC) which, depending on the deter-
gent in question, could be well into the millimolar range. 
As mentioned above, a detergent that is well-suited for
protein solubilization may not be the detergent of choice for
crystallization, and detergents can be exchanged through
dialysis or during purification while the target protein is
bound to a chromatographic column. Just as with the screen-
ing of detergents for the optimization of solubilization, a
variety of detergents should be screened during the course of
crystallization trials. An impressive range of detergents
has been used to obtain crystals yielding high-resolution
diffraction (Figure 2). From crystal-packing considerations,
detergents with the potential to yield the smallest possible
micelle region on the solubilized protein should best support
the formation of the protein-to-protein contacts needed for
crystallization. A potential downside is that smaller deter-
gents tend to have higher CMCs, requiring higher concentra-
tions to maintain protein solubility, and are more likely to
destabilize native structure. The goal should therefore be to
identify the smallest detergents that maintain homogeneous
and monodisperse solutions of structurally sound target pro-
teins. Alternatively, the use of secondary detergents or
amphiphiles as additives to alter the properties of mixed
micelles has also yielded high-quality crystals [27,28]. The
location, or mere presence, of an affinity tag may play a role
in determining whether a protein will crystallize, and it may
be advisable to conduct crystallization trials on target pro-
teins in which the polyhistidine affinity tags have been
removed. Cleavage sites engineered into the expressed
protein can be used to remove these tags using a detergent-
resistant protease.
Membrane proteins have been crystallized using vapor diffu-
sion (in which hanging and sitting drops of a solution con-
taining the target protein are allowed to equilibrate with a
reservoir solution containing a higher concentration of pre-
cipitant), and less frequently by dialysis and batch methods
(where protein, precipitant and buffer are mixed to be at or
very near the final concentrations required for crystalliza-
tion). Sparse matrix screens (relatively small sets of crystal-
lization conditions that survey a broad range of parameter
space in coarse intervals) allow for rapid sampling of a
diverse range of precipitant, pH and ionic strength conditions
[29-31] have been successfully applied and are even available
commercially (see, for example, [32]). These crystallization
and screening methods lend themselves well to high-
throughput robotics-based automation [33,34]. Recently
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Figure 2
Primary detergents used to obtain crystals of membrane proteins suitable
for high-resolution structural studies [1]. The proportion of proteins
solved with each detergent is indicated. Abbreviations: OG, n-octyl--D-
glucopyranoside; NG, n-nonyl--D-glucopyranoside; OM, n-octyl--D-
maltopyranoside; DM, n-decyl--D-maltopyranoside; UDM, n-undecyl--
D-maltopyranoside; DDM, n-dodecyl--D-maltopyranoside; TDM,
n-tridecyl--D-maltopyranoside; C8E4, polyoxyethylene (4) octyl ether;
C12E8, polyoxyethylene (8) dodecyl ether; C12E9, polyoxyethylene (9)
dodecyl ether; C10DAO, n-decyl-N,N-dimethylamine-N-oxide; LDAO,
n-dodecyl-N,N-dimethylamine-N-oxide; LAPAO, 3-laurylamido-N,N-
dimethylpropylaminoxide; FC14, n-tetradecylphosphocholine; MEGA10,
decanoyl-N-methylglucamide; DHPC, 1,2-diheptanoyl-sn-glycero-3-
phosphocholine. 
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12developed microfluidics devices can also support the rapid
setup and evaluation of extensive crystallization screens
using extremely small amounts of sample [35]. For example,
in one commercially available system it is possible to survey
up to 144 conditions from a total of 3 l of sample [36,37].
This method mixes reagent and sample through the process
of free interface diffusion, whereby the protein and reagent
are free to move throughout the system, and may allow for
novel high-throughput surveys of crystallization space. 
Techniques directly targeting the unique concerns of mem-
brane-protein crystallization have also been developed;
these include methods involving the use of lipidic cubic
phases [38] and bicelles [39]. The rationale behind these
methods is the notion that placing the solubilized protein
back into a native-like environment will improve the chances
of crystallization. Both of these approaches involve crystal-
lization of the membrane protein within the context of lipid
bilayers and have been used to produce well-ordered crystals
of bacterial rhodopsins; but it remains to be determined
to what extent the same approaches will apply to other
membrane-protein families.
NMR spectroscopy
Several different NMR technologies utilize a wide variety of
membrane-mimetic environments. Solution NMR requires
isotropic motions of the protein, and hence membrane pro-
teins must be solubilized within detergent micelles. In
homogeneous monodisperse samples, membrane proteins
typically maintain not only their secondary and tertiary
structure, but also their quaternary structure within
micelles. In solid-state NMR, membrane proteins can be
characterized in aligned planar bilayers by using orienta-
tional restraints that relate each atomic site of the protein to
a reference axis perpendicular to the plane of the lipid
bilayer. Solid-state NMR can also be used with samples that
are not uniformly aligned, such as multilamellar liposomes,
by using distance and torsional restraints that, respectively,
constrain the structure by interatomic distances or define
the relative orientation of adjacent atomic groups. Moreover,
it may be possible to characterize membrane protein struc-
ture by solid-state NMR using micro- and nano-crystals of
membrane proteins again through distance and torsional
restraints. While NMR does not require diffraction-quality
crystallization of membrane proteins, sample preparation is
still a bottleneck, whether it is at the stage of detergent solu-
bilization of the protein at high concentration, the reconsti-
tution of protein into liposomes, or the uniform alignment of
bilayer samples.
Solution NMR methodology has advanced with new proce-
dures, such as transverse relaxation optimized spectroscopy
(TROSY), that aid in data collection of samples that tumble
slowly on the NMR frequency scale (500 to 900 MHz). NMR
spectra of proteins require the use of 15N and 13C isotopic
labeling to achieve sensitivity and resolution in the spectra.
The collection of structural restraints using this methodol-
ogy is primarily from residual dipolar couplings (RDCs) that
are derived from samples that have a slight degree of align-
ment with respect to the magnetic field and nuclear Over-
hauser effect (NOE)-derived inter-proton distances from
samples that are extensively deuterated [40]. Such deutera-
tion is required to improve the resolution in 1H spectra.
Excellent progress has been made recently in the develop-
ment of partial alignment of these proteins by using
stretched polyacryamide gels that generate an anisotropic
environment for the protein [41]. In other words, the protein
in these gels has a slight preference for one orientation over
other possible orientations. For  helices, a pattern with 3.6
resonances per cycle is observed, in a phenomenon known as
a dipolar wave [42]. Because  helices have 3.6 residues per
turn about the helical axis, a pattern in the RDCs of the
backbone amide 15N resonances is observed with the same
periodicity. The amplitude of the waves represented on plots
of RDCs versus residue number is characteristic of the tilt
angle of the helix with respect to the alignment axis and the
magnetic field axis. Recent success with this approach has
resulted in submissions of structures to the PDB [43] and
progress with polytopic oligomeric proteins is progressing in
additional laboratories (see [44], for example).
In solid-state NMR two technologies are utilized [45], one
requiring aligned planar bilayer samples and the other using
magic angle spinning (MAS) samples, in which samples of
liposomes or micro- or nano-crystals are rotated about an
axis inclined at 54.7° with respect to the magnetic field. In
this way the anisotropic properties of the spectra are removed
and a solution-like spectrum is observed. Uniformly aligned
bilayers yield anisotropic observables, such as dipolar and
quadrupolar couplings, as well as anisotropic chemical shifts.
In other words, these NMR spin interactions display an ori-
entation dependence with respect to the axis of the magnetic
field of the NMR spectrometer. In this way the observed cou-
plings and chemical shifts can be related to the orientation of
the atomic sites with respect to the bilayer normal, which is
aligned parallel to the magnetic field. As for the dipolar waves
described above, the spectra of uniformly aligned samples in
which the 15N-1H dipolar interaction is correlated with the 15N
chemical shift, result in circular patterns of resonances for
-helical segments with 3.6 resonances per turn, reminiscent
of helical wheels. Here the patterns, known as PISA wheels
[46,47], represent an opportunity to assess helix tilt angles
and orientations without the need for, or with minimal, reso-
nance assignments, respectively. This methodology repre-
sents an excellent screening tool for low-resolution structural
information. Spectral sensitivity and resolution have been
dramatically improved in the past decade, such that back-
bone structures of small proteins are now possible, and com-
plete structures of peptides have been demonstrated. MAS
experiments lead to distance and torsion restraints that are
highly complementary to orientational restraints. Resolution
is dramatically improved in MAS experiments by using
215.6 Genome Biology 2004, Volume 5, Issue 4, Article 215 Walian et al. http://genomebiology.com/2004/5/4/215
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ment of each protein is nearly identical.
While the first solid-state NMR structure was deposited in
the PDB in 1997, since then another nine structures have
been deposited in the data bank, and these nine were deter-
mined using either uniformly aligned samples or MAS
samples. In addition, the structures of three -barrel mem-
brane proteins have been solved by solution NMR.
Electron crystallography
Two-dimensional crystals, which are sheet-like crystals one
unit-cell thick, are ideally suited for electron-crystallographic
structure-determination methods. Membrane proteins crys-
tallized within the context of lipid bilayers represent one
excellent example; numerous electron crystallography struc-
tural studies of membrane proteins have been performed
using such specimens. There is no ‘phase problem’ in electron
crystallography as there is in X-ray crystallography, since
electron micrographs of crystalline samples yield images
from which phases can be determined directly. To produce a
structural dataset consisting of diffraction amplitudes and
phases, electron diffraction patterns (to obtain more accurate
amplitudes) and electron micrographs (to obtain phases) are
collected from tilted and untilted two-dimensional crystals.
These data are subsequently processed and merged into
three-dimensional sets of structure factors. Three-dimen-
sional density maps of the target molecules obtained from
their structure factors are then modeled and interpreted in
much the same manner as electron density maps derived
from X-ray diffraction data. Recent improvements in electron
microscope automation have led to increased data-collection
rates and reduced processing times. 
Naturally occurring two-dimensional crystals of bacteri-
orhodopsin (found in the purple membrane of halobacteria)
have yielded the best quality electron crystallographic data
from a membrane protein to date, allowing an atomic-level
model of this membrane protein to be obtained [48,49]. A
substantial number of detergent-solubilized membrane pro-
teins have been reconstituted to form two-dimensional crys-
tals, some very well ordered and over 1 m in size. Because of
limits in sample tilting, however, the distribution of resolu-
tion in density maps produced from two-dimensional crystals
is anisotropic. The quality of diffraction, in the best direc-
tion, from the most useful of these crystals has ranged from
about 7 Å resolution, which is sufficient to reveal the pres-
ence of transmembrane helices, up to the 4 to 3 Å resolution
range, where the main chain of the polypeptide can be
modeled and the larger side chains assigned.
Several methodologies have evolved for obtaining two-
dimensional crystals from solubilized membrane proteins;
these include reconstitution of membrane proteins into lipid
bilayers, and crystallization along lipid monolayers at air-
water interfaces or on preformed lipid tubes [50]. The
approach based on lipid-bilayer reconstitution is the only
method that to date has yielded high-resolution structural
data. The reconstitution procedures involve mixing the
detergent-solubilized target protein and lipid at relatively
low lipid-to-protein ratios, followed by removal, or reduction
in the concentration, of detergent. This may be done by dial-
ysis, by adsorption of detergent to polystyrene beads, or by
dilution of the sample. Upon removal of detergent, protein
and lipid can associate to form membranes with a high
density of proteins; under appropriate conditions, these are
organized into crystalline arrays. The formation and quality
of the resulting crystals depend on parameters such as the
choice of lipid, protein concentration, protein-to-lipid ratio,
detergents, rates of detergent removal, temperature and
other factors, such as pH and ionic strength that are often
found useful in three-dimensional protein crystallization. As
with the other structure-determination techniques described
above, the target membrane protein to be studied should be
in a pure, homogeneous and stable state. The protein con-
centration required for these experiments is, however,
substantially lower than for X-ray and NMR methods, at
about 1 mg/ml. 
Frontiers of membrane-protein structural
determination 
Dramatic improvements in a range of technologies associ-
ated with membrane-protein structure determination have
been realized over the past ten years, particularly in the
areas of protein solubilization, crystallization and NMR
sample preparation, as well as data collection and process-
ing. Automation of processes in some of these areas is
expected to further accelerate progress. The availability of a
broad spectrum of fully sequenced genomes, coupled with
advanced molecular biology techniques, means that literally
thousands of membrane proteins can be made available for
study. Clearly the time is right for membrane-protein struc-
tural genomics efforts to move into full swing. 
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